The FTSE 100 slumps! I’d buy these 2 bargain shares today to get rich and retire early

These two FTSE 100 (INDEXFTSE:UKX) shares could offer good value for money in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 has experienced a highly challenging period in recent weeks. Its price level has fallen by around 8% since the start of the year, with investors becoming increasingly concerned about the impact of the tragic coronavirus on company earnings.

In the short run, further falls in the FTSE 100 would be unsurprising. However, for long-term investors the index’s current woes (like all such downturns) could present a buying opportunity. A number of large-cap shares currently trade on low valuations, which may allow investors to obtain favourable risk/reward ratios.

With that in mind, here are two FTSE 100 shares that could be worth buying today while they offer wide margins of safety.

Taylor Wimpey

Taylor Wimpey (LSE: TW) recently reported an impressive set of results for the 2019 financial year. A 5% rise in completions boosted the housebuilder’s revenue by 6.4%, while demand for new homes has continued to be resilient.

Looking ahead, the company is forecast to post a 4% rise in its bottom line next year. Although it faces risks such as the outcome of Brexit talks and a weaker near-term outlook for the world economy, Taylor Wimpey’s price-to-earnings (P/E) ratio of 10 suggests that investors have included a wide margin of safety in its valuation.

The stock’s dividend appeal continues to be higher than most of its FTSE 100 peers. It currently yields 9%, while its net cash position and large pipeline of homes means that its dividend affordability could be relatively high.

As such, now could be the right time to buy a slice of the business. It may face a challenging near-term outlook alongside most of the FTSE 100. But with a high yield, a low valuation and the potential to benefit from resolute demand for properties in the UK, its returns could prove to be very impressive in the long run.

HSBC

The recent annual results from HSBC (LSE: HSBA) highlighted that parts of its business face a difficult outlook. For example, it is now assuming a lower long-term economic growth rate across a number of its segments. This contributed to it recording a goodwill impairment of $7.3bn for the year.

Looking ahead, the bank will attempt to reduce its costs to become more competitive. Its progress looks set to be hampered by a potential slowdown in key economies across Asia due to the spread of coronavirus. This is likely to have contributed to its share price fall of 11% since the start of the year.

However, since the stock now trades on a P/E ratio of 10.2, it appears to offer good value for money. It plans to sustain its dividend over the medium term, which means that its income return of 7.4% could prove to be highly attractive.

Therefore, now could be an opportune moment to buy shares in HSBC while it is experiencing a challenging set of operating conditions. It appears to have long-term recovery potential.

Peter Stephens owns shares of HSBC Holdings and Taylor Wimpey. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »